This strategy tends to hold larger, more undervalued companies compared with its average peer in the Health Morningstar Category. Analyzing additional factors, this strategy consistently held some ...

For most of manager Giri Devulapally’s 20-year tenure, the strategy carried higher price multiples than the index and large growth Morningstar Category peers. In 2021 and 2022, however ...